Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06056921
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-08-18
Brief Title:
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
Sponsor:
Organization:
Chongqing Precision Biotech Co Ltd